The central government is reviewing complaints that hospitals, particularly private facilities, are charging patients several times more than the purchase price of medicines, medical devices and treatment consumables. The review will compare hospitals’ actual procurement costs with the amounts recorded on patient bills before the government decides on further action.
According to sources cited by Jagran in the Ministry of Chemicals and Fertilizers, the exercise is examining the prices at which hospitals buy products from manufacturers or the market and the amounts later recovered from patients. The government is not expected to assess billing only against a product’s maximum retail price (MRP). The gap between the hospital’s actual purchase price and the patient’s billed amount will also be considered.
The review follows scrutiny of hospital procurement and billing records in Maharashtra, where officials reportedly found significant differences for commonly used medical consumables. In one case, an intravenous set purchased for about ₹11 was listed on a patient’s bill at up to ₹325. A catheter bought for around ₹29 was billed at ₹310, while a syringe costing approximately ₹7 was charged at up to ₹57.
The records also showed cases in which nebulisers and oxygen masks purchased for ₹40-45 were billed to patients at prices ranging from ₹650 to ₹715. Intravenous sets, syringes, catheters, oxygen masks and similar consumables are routinely used during hospital treatment, particularly for inpatients.
These charges can be difficult for patients to verify while they are receiving treatment. Hospitalised patients may not be able to compare prices easily or purchase supplies independently from outside. Where there is a large difference between procurement costs and billed prices, the mark-up can add substantially to the overall cost of treatment.
The issue is also being examined in relation to in-house hospital pharmacies, where patients may have limited ability to choose another source for medicines. Following the cases identified in Maharashtra, the ministry is reviewing the relationship between hospital procurement prices and the amounts recovered from patients. Discussions are also being held with stakeholders connected to the hospital sector.
Hospital operators have argued that the difference between procurement prices and patient charges cannot automatically be treated as profit. Their stated position is that billed amounts may include costs related to storage, staffing, infection control, supply management and other hospital operations. The ministry’s review is considering these factors while examining whether trade margins can be made more rational.
The review therefore places hospital billing within a wider regulatory question: how should healthcare facilities account for legitimate operating costs while ensuring that patients are not exposed to excessive or opaque charges for essential supplies? The supplied report does not specify a final cap, revised billing rule or implementation timeline.
According to the ministry sources cited in the report, the government will decide on the required arrangements and measures after the review is completed. The next step will depend on the conclusions reached from the procurement and billing assessment and consultations with hospital-sector stakeholders.
